Osęka , M., Saładziak , K., Jamrozy-Witkowska , A., Dziedziak , J., Cudnoch-Jędrzejewska , A. and Święch , A. 2020. The potential usage of D2 dopaminergic agonists in the treatment of VEGF-related eye diseases. OphthaTherapy. Therapies in Ophthalmology. 7, 1 (Mar. 2020), 36-39. DOI:https://doi.org/10.24292/01.OT.310320.05.